Table 2 Comparison of the chemotherapy regimens between the two groups [case(%)]
Item | Observation (n = 265) | Control (n = 163) | P |
|---|---|---|---|
CHOP | 10 (3.8) | 6 (3.7) | 0.961 |
CP | 4 (1.5) | 0(0) | 0.302 |
DP | 2 (0.8) | 3 (1.8) | 0.374 |
DVP | 0 (0) | 1 (0.6) | 0.381 |
FOLFIRI | 14 (5.3) | 7 (4.3) | 0.646 |
FOLFOX | 76 (28.7) | 39 (23.9) | 0.281 |
GP | 26 (9.8) | 19 (11.7) | 0.546 |
IP | 2 (0.8) | 0 (0) | 0.527 |
NF | 11 (4.2) | 6 (3.7) | 0.809 |
NP | 39 (14.7) | 30 (18.4) | 0.314 |
PVB | 0 (0) | 2 (1.2) | 0.144 |
PVD | 2 (0.8) | 2 (1.2) | 0.637 |
TA | 25 (9.4) | 13 (8) | 0.606 |
TF | 6 (2.3) | 9 (5.5) | 0.075 |
TOX | 2 (0.8) | 0 (0) | 0.527 |
TP | 44 (16.6) | 24 (14.7) | 0.605 |
VA | 0 (0) | 2 (1.2) | 0.144 |
VP | 2 (0.8) | 0 (0) | 0.527 |